FIM
ABBV icon

FWL Investment Management’s AbbVie ABBV Stock Holding History

FWL Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Buy
5,047
+182
+4% +$39.2K 0.23% 59
2026
Q1 		$1.06M Buy
4,865
+3,676
+309% +$815K 0.23% 54
2025
Q4 		$272K Buy
1,189
+182
+18% +$41.5K 0.07% 76
2025
Q3 		$233K Sell
1,007
-90
-8% -$18.3K 0.06% 79
2025
Q2 		$204K Sell
1,097
-162
-13% -$30.1K 0.06% 87
2025
Q1 		$264K Sell
1,259
-4
-0.3% -$778 0.1% 73
2024
Q4 		$224K Buy
1,263
+150
+13% +$27.6K 0.08% 76
2024
Q3 		$220K Buy
1,113
+204
+22% +$38.1K 0.08% 71
2024
Q2 		$156K Sell
909
-337
-27% -$55.8K 0.08% 54
2024
Q1 		$227K Buy
1,246
+540
+76% +$93.1K 0.13% 54
2023
Q4 		$109K Buy
706
+406
+135% +$59.2K 0.06% 62
2023
Q3 		$44.7K Buy
+300
New +$44K 0.03% 98
2023
Q1 		– Sell
-300
Closed -$48.5K – 75
2022
Q4 		$48.5K Buy
+300
New +$46K 0.04% 94

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

FWL Investment Management's ABBV Position: Q2 2026 in Review

FWL Investment Management increased its AbbVie (ABBV) stake by 3.7% in Q2 2026, buying an estimated $39.2K and bringing the position to 5,047 shares worth $1.27M. The position accounts for 0.23% of the portfolio, ranked #59.

FWL Investment Management first reported a position in ABBV in Q4 2022 and has held it in 13 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • FWL Investment Management held 5,047 shares of AbbVie worth $1.27M as of Q2 2026.
  • FWL Investment Management bought 182 AbbVie shares in Q2 2026, an estimated $39.2K.
  • AbbVie made up 0.23% of FWL Investment Management's portfolio in Q2 2026, its #59 holding.
  • FWL Investment Management first reported a position in AbbVie in Q4 2022 and has held it in 13 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on FWL Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.